The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase

eLife

Joachim Seemann¹  Russell A DeBose-Boyd²  Youngah Jo³  Rania Elsabrouty³  Marc M Schumacher³ 

[1] Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, United States;Department of Molecular Genetics, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, United States;Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, United States;

关键词: ER associated degradation;    cholesterol metabolism;    prenyltransferase;    vitamin K;    isoprenoid;   

DOI  :  10.7554/eLife.05560

来源: DOAJ

【 摘 要 】

Schnyder corneal dystrophy (SCD) is an autosomal dominant disorder in humans characterized by abnormal accumulation of cholesterol in the cornea. SCD-associated mutations have been identified in the gene encoding UBIAD1, a prenyltransferase that synthesizes vitamin K2. Here, we show that sterols stimulate binding of UBIAD1 to the cholesterol biosynthetic enzyme HMG CoA reductase, which is subject to sterol-accelerated, endoplasmic reticulum (ER)-associated degradation augmented by the nonsterol isoprenoid geranylgeraniol through an unknown mechanism. Geranylgeraniol inhibits binding of UBIAD1 to reductase, allowing its degradation and promoting transport of UBIAD1 from the ER to the Golgi. CRISPR-CAS9-mediated knockout of UBIAD1 relieves the geranylgeraniol requirement for reductase degradation. SCD-associated mutations in UBIAD1 block its displacement from reductase in the presence of geranylgeraniol, thereby preventing degradation of reductase. The current results identify UBIAD1 as the elusive target of geranylgeraniol in reductase degradation, the inhibition of which may contribute to accumulation of cholesterol in SCD.

【 授权许可】

Unknown